The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...

new UK clinical trials draft legislation, Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 (the UK Regulations), was introduced in December 2024 and became law on April 10 ...

Representatives of industry and regulation will meet in June to discuss paths forward for the UK’s clinical trials sector ...

The UK’s Office of Life Sciences (OLS) has commissioned an independent review of the country’s commercial clinical trials sector, following the publication of an industry report which found a ...

Clinical trials are strictly regulated to ensure patient safety, but the current framework in the UK is stifling early-phase clinical research, making it harder to advance novel therapies through ...

Following a 2023 review of the UK clinical trial landscape, Lord James O’Shaughnessy, the former health minister highlighted major change since the report’s publication, but asked ...